Cargando…
The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective
Continuing reports of new SARS-CoV-2 variants have caused worldwide concern and created a challenging situation for clinicians. The recently reported variant B.1.618, which possesses the E484K mutation specific to the receptor-binding domain (RBD), as well as two deletions of Tyr145 and His146 at th...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040812/ https://www.ncbi.nlm.nih.gov/pubmed/35480256 http://dx.doi.org/10.1039/d1ra04694b |
_version_ | 1784694411864571904 |
---|---|
author | Khan, Abbas Gui, Jianjun Ahmad, Waqar Haq, Inamul Shahid, Marukh Khan, Awais Ahmed Shah, Abdullah Khan, Arsala Ali, Liaqat Anwar, Zeeshan Safdar, Muhammad Abubaker, Jehad Uddin, N. Nizam Cao, Liqiang Wei, Dong-Qing Mohammad, Anwar |
author_facet | Khan, Abbas Gui, Jianjun Ahmad, Waqar Haq, Inamul Shahid, Marukh Khan, Awais Ahmed Shah, Abdullah Khan, Arsala Ali, Liaqat Anwar, Zeeshan Safdar, Muhammad Abubaker, Jehad Uddin, N. Nizam Cao, Liqiang Wei, Dong-Qing Mohammad, Anwar |
author_sort | Khan, Abbas |
collection | PubMed |
description | Continuing reports of new SARS-CoV-2 variants have caused worldwide concern and created a challenging situation for clinicians. The recently reported variant B.1.618, which possesses the E484K mutation specific to the receptor-binding domain (RBD), as well as two deletions of Tyr145 and His146 at the N-terminal binding domain (NTD) of the spike protein, must be studied in depth to devise new therapeutic options. Structural variants reported in the RBD and NTD may play essential roles in the increased pathogenicity of this SARS-CoV-2 new variant. We explored the binding differences and structural-dynamic features of the B.1.618 variant using structural and biomolecular simulation approaches. Our results revealed that the E484K mutation in the RBD slightly altered the binding affinity through affecting the hydrogen bonding network. We also observed that the flexibility of three important loops in the RBD required for binding was increased, which may improve the conformational optimization and consequently binding of the new variant. Furthermore, we found that deletions of Tyr145 and His146 at the NTD reduced the binding affinity of the monoclonal antibody (mAb) 4A8, and that the hydrogen bonding network was significantly affected consequently. This data show that the new B.1.618 variant is an antibody-escaping variant with slightly altered ACE2–RBD affinity. Moreover, we provide insights into the binding and structural-dynamics changes resulting from novel mutations in the RBD and NTD. Our results suggest the need for further in vitro and in vivo studies that will facilitate the development of possible therapies for new variants such as B.1.618. |
format | Online Article Text |
id | pubmed-9040812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-90408122022-04-26 The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective Khan, Abbas Gui, Jianjun Ahmad, Waqar Haq, Inamul Shahid, Marukh Khan, Awais Ahmed Shah, Abdullah Khan, Arsala Ali, Liaqat Anwar, Zeeshan Safdar, Muhammad Abubaker, Jehad Uddin, N. Nizam Cao, Liqiang Wei, Dong-Qing Mohammad, Anwar RSC Adv Chemistry Continuing reports of new SARS-CoV-2 variants have caused worldwide concern and created a challenging situation for clinicians. The recently reported variant B.1.618, which possesses the E484K mutation specific to the receptor-binding domain (RBD), as well as two deletions of Tyr145 and His146 at the N-terminal binding domain (NTD) of the spike protein, must be studied in depth to devise new therapeutic options. Structural variants reported in the RBD and NTD may play essential roles in the increased pathogenicity of this SARS-CoV-2 new variant. We explored the binding differences and structural-dynamic features of the B.1.618 variant using structural and biomolecular simulation approaches. Our results revealed that the E484K mutation in the RBD slightly altered the binding affinity through affecting the hydrogen bonding network. We also observed that the flexibility of three important loops in the RBD required for binding was increased, which may improve the conformational optimization and consequently binding of the new variant. Furthermore, we found that deletions of Tyr145 and His146 at the NTD reduced the binding affinity of the monoclonal antibody (mAb) 4A8, and that the hydrogen bonding network was significantly affected consequently. This data show that the new B.1.618 variant is an antibody-escaping variant with slightly altered ACE2–RBD affinity. Moreover, we provide insights into the binding and structural-dynamics changes resulting from novel mutations in the RBD and NTD. Our results suggest the need for further in vitro and in vivo studies that will facilitate the development of possible therapies for new variants such as B.1.618. The Royal Society of Chemistry 2021-09-09 /pmc/articles/PMC9040812/ /pubmed/35480256 http://dx.doi.org/10.1039/d1ra04694b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Khan, Abbas Gui, Jianjun Ahmad, Waqar Haq, Inamul Shahid, Marukh Khan, Awais Ahmed Shah, Abdullah Khan, Arsala Ali, Liaqat Anwar, Zeeshan Safdar, Muhammad Abubaker, Jehad Uddin, N. Nizam Cao, Liqiang Wei, Dong-Qing Mohammad, Anwar The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
title | The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
title_full | The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
title_fullStr | The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
title_full_unstemmed | The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
title_short | The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
title_sort | sars-cov-2 b.1.618 variant slightly alters the spike rbd–ace2 binding affinity and is an antibody escaping variant: a computational structural perspective |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040812/ https://www.ncbi.nlm.nih.gov/pubmed/35480256 http://dx.doi.org/10.1039/d1ra04694b |
work_keys_str_mv | AT khanabbas thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT guijianjun thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT ahmadwaqar thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT haqinamul thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT shahidmarukh thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT khanawaisahmed thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT shahabdullah thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT khanarsala thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT aliliaqat thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT anwarzeeshan thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT safdarmuhammad thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT abubakerjehad thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT uddinnnizam thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT caoliqiang thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT weidongqing thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT mohammadanwar thesarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT khanabbas sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT guijianjun sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT ahmadwaqar sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT haqinamul sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT shahidmarukh sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT khanawaisahmed sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT shahabdullah sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT khanarsala sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT aliliaqat sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT anwarzeeshan sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT safdarmuhammad sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT abubakerjehad sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT uddinnnizam sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT caoliqiang sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT weidongqing sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective AT mohammadanwar sarscov2b1618variantslightlyaltersthespikerbdace2bindingaffinityandisanantibodyescapingvariantacomputationalstructuralperspective |